Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,735 USD | +2,45% | +4,47% | -75,01% |
Omzet 2024 * | 4,6 mln. 4,3 mln. | Omzet 2025 * | 1,3 mln. 1,22 mln. | Marktkapitalisatie | 29,52 mln. 27,59 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -49 mln. -45,8 mln. | Nettowinst (verlies) 2025 * | -60 mln. -56,08 mln. | EV/omzet 2024 * | -3,17 x |
Nettoliquiditeiten 2024 * | 44,1 mln. 41,22 mln. | Nettoliquiditeiten 2025 * | 89,5 mln. 83,65 mln. | EV/omzet 2025 * | -46,1 x |
K/w-verhouding 2024 * |
-0,61
x | K/w-verhouding 2025 * |
-0,71
x | Werknemers | 29 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 88,37% |
Recentste transcriptie over Spruce Biosciences, Inc.
1 dag | +1,33% | ||
1 week | +2,22% | ||
Lopende maand | +1,33% | ||
1 maand | -12,49% | ||
3 maanden | -79,15% | ||
6 maanden | -35,95% | ||
Lopend jaar | -75,52% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 54 | 03-01-22 | |
Samir Gharib
DFI | Director of Finance/CFO | 41 | 01-05-20 |
Michael Grey
CHM | Chairman | 71 | 01-04-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Dan Spiegelman
BRD | Director/Board Member | 65 | 09-09-20 |
Michael Grey
CHM | Chairman | 71 | 01-04-17 |
Tiba Aynechi
BRD | Director/Board Member | 48 | 01-05-16 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
02-05-24 | 0,7323 | +2,08% | 121 102 |
01-05-24 | 0,7174 | +1,33% | 754 833 |
30-04-24 | 0,708 | -0,28% | 243 404 |
29-04-24 | 0,71 | +1,43% | 255 561 |
26-04-24 | 0,7 | -0,14% | 211 577 |
uitgestelde koers Nasdaq, 01 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-75,52% | 29,52 mln. | |
+0,67% | 42,4 mld. | |
+46,23% | 40,04 mld. | |
-6,20% | 28,31 mld. | |
+6,55% | 24,94 mld. | |
-21,66% | 18,96 mld. | |
+29,96% | 12,3 mld. | |
-1,57% | 11,95 mld. | |
+16,03% | 11,32 mld. | |
-4,80% | 11,55 mld. |